ZOMETA® Dosing & Administration-Dosing for Administration For Bone Metastases-Dose every 3 to 4 weeks

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

Page

1 2 3 4

Dose ZOMETA^® 4 mg every 3 to 4 weeks for patients with advanced malignancies involving bone

For patients with advanced malignancies involving bone, the recommended regimen is ZOMETA^® 4 mg every 3 to 4 weeks¹
No other dosing regimen has been tested and proven to protect patients from skeletal-related events (SREs)^2-5

Page

1 2 3 4

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

Dose ZOMETA® 4 mg every 3 to 4 weeks for patients with advanced malignancies involving bone

Dose ZOMETA^® 4 mg every 3 to 4 weeks for patients with advanced malignancies involving bone